Zhang, J., Qi, Y., Ma, N., Lu, F., Gong, W., Chen, B., . . . Li, L. (2020). Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma. J Cancer.
Style de citation ChicagoZhang, Jie, et al. "Overexpression of Epcam and CD133 Correlates With Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma." J Cancer 2020.
Style de citation MLAZhang, Jie, et al. "Overexpression of Epcam and CD133 Correlates With Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma." J Cancer 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.